Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Ishares Genomics Immunology and Healthcare ETF (IDNA)

Ishares Genomics Immunology and Healthcare ETF (IDNA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 271,622,000
  • Shares Outstanding, K 6,200
  • 60-Month Beta 0.82
Trade IDNA with:
  • Price/Earnings ttm 28.20
  • Annual Dividend & Yield 0.12
  • Most Recent Dividend 0.036
  • Management Fee 0.47%
  • Sectors:

Options Overview

Details
  • Implied Volatility 24.03%
  • Historical Volatility 37.36%
  • IV Percentile 2%
  • IV Rank 11.78%
  • IV High 107.36% on 07/07/20
  • IV Low 12.91% on 03/22/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 5
  • Volume Avg (30-Day) 6
  • Put/Call OI Ratio 1.58
  • Today's Open Interest 488
  • Open Int (30-Day) 42

Price Performance

See More
Period Period Low Period High Performance
1-Month
42.70 +5.22%
on 03/30/21
48.50 -7.36%
on 03/22/21
-2.36 (-4.99%)
since 03/12/21
3-Month
40.84 +10.01%
on 03/05/21
55.03 -18.35%
on 02/10/21
-4.74 (-9.54%)
since 01/13/21
52-Week
28.29 +58.82%
on 04/15/20
55.03 -18.35%
on 02/10/21
+17.02 (+60.98%)
since 04/13/20

Most Recent Stories

More News
Top-Performing Biotech ETFs Amid the COVID-19 Crisis

The coronavirus pandemic triggered a race to introduce vaccine and treatment, thereby opening up new investing opportunities in the biotech sector in 2020.

XBI : 128.91 (+1.46%)
BTEC : 57.07 (+1.75%)
ARKG : 89.32 (+3.12%)
GNOM : 22.36 (+2.95%)
IDNA : 44.93 (+2.53%)
Moderna ETFs to Shine on Vaccine News as Outbreak Worsens

Positive coronavirus vaccine progress from Moderna (MRNA) has hogged investors' attention.

IBB : 149.21 (+1.85%)
XBI : 128.91 (+1.46%)
BBH : 178.70 (+1.85%)
BTEC : 57.07 (+1.75%)
IDNA : 44.93 (+2.53%)
GERM : 35.21 (+3.27%)
ETFs in Focus on Bayer's Bet on Gene Therapy

Bayer has made a big bet on gene therapy by announcing the acquisition of U.S. biotech firm Asklepios BioPharmaceutical for as much as $4 billion.

PBE : 73.63 (+1.78%)
ARKG : 89.32 (+3.12%)
GNOM : 22.36 (+2.95%)
IDNA : 44.93 (+2.53%)
Moderna Expects COVID-19 Vaccine Data in November: ETFs to Gain

Positive comment on coronavirus vaccine progress from Moderna's (MRNA) CEO during The Wall Street Journal's annual Tech Live conference has gained investors attention and raised vaccine optimism.

IBB : 149.21 (+1.85%)
XBI : 128.91 (+1.46%)
BBH : 178.70 (+1.85%)
BTEC : 57.07 (+1.75%)
IDNA : 44.93 (+2.53%)
GERM : 35.21 (+3.27%)
Why You Should Invest in Genomics ETFs

Genomics ETFs have surged of late; here's why

REGN : 477.04 (+0.90%)
GILD : 64.89 (+0.36%)
NVTA : 39.38 (+4.71%)
CRSP : 120.88 (+5.67%)
ARKG : 89.32 (+3.12%)
GNOM : 22.36 (+2.95%)
IDNA : 44.93 (+2.53%)
Genomics ETFs Surge on Nobel Prize for Gene-Editing Pioneers

The announcement of the 2020 Nobel Prize winners for Chemistry has successfully brought investor attention to the gene-editing space.

PBE : 73.63 (+1.78%)
ARKG : 89.32 (+3.12%)
GNOM : 22.36 (+2.95%)
IDNA : 44.93 (+2.53%)
Healthcare ETFs, Stocks That Gained Double Digits Last Week

The healthcare sector defied last week's market rout buoyed by the progress in the development of a coronavirus vaccine or treatment, and merger and acquisition news.

AZN : 49.19 (-0.47%)
PFE : 37.16 (+0.51%)
GILD : 64.89 (+0.36%)
IMMU : 87.86 (+0.05%)
MRNS : 14.16 (+1.22%)
PTH : 152.21 (+0.64%)
WVE : 6.44 (+1.42%)
BBC : 47.71 (+0.94%)
BTEC : 57.07 (+1.75%)
NVUS : 14.60 (-5.19%)
SAVA : 36.03 (+0.19%)
IDNA : 44.93 (+2.53%)
IBBJ : 31.68 (+1.24%)
Moderna ETFs to Gain on New Positive COVID-19 Vaccine Data

Per the latest data from an early stage clinical trial, Moderna's experimental coronavirus vaccine is successfully producing neutralizing antibodies and T-cells in older adults.

MRNA : 149.71 (+7.40%)
IBB : 149.21 (+1.85%)
CNCR : 28.00 (+0.32%)
XBI : 128.91 (+1.46%)
BBH : 178.70 (+1.85%)
BTEC : 57.07 (+1.75%)
IDNA : 44.93 (+2.53%)
GERM : 35.21 (+3.27%)
Why Small-Cap Biotech ETFs Are Good Long-Term Bets

Small-cap biotech ETFs may prove to be winning bets with or without coronavirus.

BBC : 47.71 (+0.94%)
BTEC : 57.07 (+1.75%)
IDNA : 44.93 (+2.53%)
IBBJ : 31.68 (+1.24%)
Moderna ETFs to Shine on U.S. Contracts for Coronavirus Vaccine

Moderna has inked a $1.5-billion coronavirus vaccine supply agreement with the U.S. government.

MRNA : 149.71 (+7.40%)
IBB : 149.21 (+1.85%)
CNCR : 28.00 (+0.32%)
XBI : 128.91 (+1.46%)
BBH : 178.70 (+1.85%)
BTEC : 57.07 (+1.75%)
IDNA : 44.93 (+2.53%)
GERM : 35.21 (+3.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Fund Summary

The iShares Genomics Immunology and Healthcare ETF seeks to track the investment results of an index composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology, and bioengineering.

See More

Top 10 Holdings

Name % Holdings
BEIGENE LTD 5.79%
FATE THERAPEUTIC 5.06%
EXELIXIS INC 4.94%
GILEAD SCI 4.24%
MERCK 4.22%
Sanofi 3.99%
Regeneron Pharmaceuticals Inc 3.88%
BioNTech SE 3.83%
EVOTEC 3.72%
Blueprint Medicines Corp 3.65%

See More

Key Turning Points

3rd Resistance Point 46.45
2nd Resistance Point 45.74
1st Resistance Point 45.33
Last Price 44.93
1st Support Level 44.21
2nd Support Level 43.50
3rd Support Level 43.09

See More

52-Week High 55.03
Last Price 44.93
Fibonacci 61.8% 44.82
Fibonacci 50% 41.66
Fibonacci 38.2% 38.50
52-Week Low 28.29

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar